A metabolite derived from the airway microbiome, indole-3-acetic acid (IAA), could become a potential therapeutic candidate for chronic obstructive pulmonary disease (COPD). Researchers at South China ...
CSA Medical, Inc., a medical device company focused on interventional pulmonary therapies, today announced the submission of ...
Background Exacerbations are major causes of morbidity in individuals with chronic respiratory diseases such as chronic ...
The Baylor Medicine Airway Disease Program provides comprehensive services for all patients with asthma and chronic obstructive pulmonary disease (COPD). Our physicians offer the full spectrum of ...
Chronic obstructive pulmonary disease (COPD), also known as chronic obstructive lung disease (COLD), chronic obstructive airway disease (COAD), chronic airflow limitation (CAL) and chronic obstructive ...
Acute exacerbations in chronic obstructive pulmonarydisease (COPD) and asthma are potentiallylife-threatening clinical events that may result insubstantial morbidity and mortality. Treatment ofthese ...
Chronic obstructive pulmonary disease (COPD) is a chronic, incurable condition, which is the third leading cause of death in the U.S. People with COPD experience shortness of breath, wheezing, and ...
Continuous home oxygen therapy for chronic obstructive pulmonary disease seems more cost-effective than other health technologies covered by Medicare, while nocturnal oxygen therapy is not. : A Markov ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback